Sevelamer Carbonate Tablet
Product Images NDC 11788-116

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Sevelamer Carbonate (NDC 11788-116). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aiping Pharmaceutical, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image Description (800mg 270)

This is information about a medication in the form of film-coated tablets containing 800 mg Sevelamer carbonate. The text provides storage instructions, dosage information, and the manufacturer's details. It is essential to store the tablets at 20° to 25°C (68° to 774), with excursions allowed between 15°C to 30°C (59°F to 86°F). The medication should be dispensed in a tight container and protected from moisture.*

FDA Label Image

Figure-1 (Fig 1)

FDA Label Image

Figure-2 (Fig 2)

FDA Label Image

Figure-3 (Fig 3)

This text provides data on the percentage of patients with reduction in serum phosphorus levels after treatment with Sevelamer Hydrochloride compared to an active control. It shows the breakdown of patients' outcomes in terms of improvement or worsening of serum phosphorus levels from baseline. The data is presented in a table format showing the reduction in serum phosphorus in mg/dL.*

FDA Label Image

Figure-4 (Fig 4)

This is a data table showing the change in phosphorus levels from baseline in a study where Sevelamer Hydrochloride is tested as an active control treatment over a period of 52 weeks.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.